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Abstract: 
 
Transcranial direct current stimulation (tDCS) may potentially enhance language therapy 
outcomes in aphasia. We report behavioral results for twelve participants with chronic aphasia 
matched for severity and randomized to receive anodal, cathodal or sham stimulation to the left 
hemisphere, concurrent with intensive speech-language therapy. Importantly, tDCS (1mA for 13 
minutes) given 5 days a week over a prolonged period of time (6 weeks) was found to be safe. 
There was an advantage of both anodal and cathodal stimulation over sham stimulation.  
Cathodal stimulation to the left hemisphere may be a viable option and should not be overlooked 
in future research.  
 
Summary: 
 
Methods that modulate cortical excitability have potential as adjuvant treatments for aphasia. 
Transcranial direct current stimulation (tDCS) is non-invasive with clinical advantages over 
other methods, in that it is portable, relatively simple and inexpensive to administer, with 
minimal side effects to participants. Furthermore, tDCS can be administered easily 
simultaneously with behavioral speech-language therapy (SLT).   
 
With tDCS, constant weak electrical currents are delivered to the cortex via two electrodes 
placed on the scalp: an active electrode overlying the cortical target and a reference electrode 
usually placed over the contralateral supraorbital area. The nature of the effect depends on the 
polarity of the current. Generally, anodal tDCS has an excitatory effect believed to result from 
partial depolarizartion of superficial cortical axons; cathodal tDCS induces inhibition via 
presumed hyperpolarization.  
Several studies have investigated the adjuvant effects of tDCS in acute (You et al, 2011) and 
chronic aphasia (Baker et al., 2010; Fiori et al., 2010; Fridriksson et al, 2011; Vines et al., 2011) 
administered simultaneously with SLT. These studies provided no more than 2 weeks of tDCS in 
combination with a range of treatments, from”traditional” SLT, to single word naming treatment, 
and MIT. Results varied and highlight the need for further exploratory investigations of tDCS in 
aphasia, especially with regard to preferred hemisphere, site of application and polarity (anodal 
vs cathodal) of the stimulation. Additionally, investigating longer periods of tDCS and in 
combination with different SLTs is warranted.  
 
We report behavioral results from a Phase 1 single-blind placebo-controlled safety and feasibility 
trial that assessed tDCS in combination with SLT. 
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Method: 
Study design 
Twelve participants with chronic aphasia were randomized to receive anodal, cathodal or sham 
tDCS to the left hemisphere for six weeks, concurrent with the same intensive SLT. Assessments 
were conducted at three time points: pretreatment; post-treatment; and at six-weeks follow-up.   
 
Subjects: 
Demographic characteristics are presented in Table 1.   
 
fMRI tasks: 
Participants underwent fMRI on a Siemens 3.0 Tesla Trio Tim whole body system with a 32-
channel head coil, before the six weeks of therapy. The pre-treatment scan was used to identify 
an individualized site for the tDCS electrode placement. Three speech-language tasks were 
performed during fMRI: a semantic categorization task; a task where a highlighted word within a 
sentence was read out loud; and imitation of consonant-vowel syllables. These tasks have been 
shown to activate overlapping areas of the brain (e.g., lateral premotor cortex, inferior prefrontal 
cortex) during word production. Intersection of activation between any two tasks was selected as 
the preferred site of stimulation.  
Daily treatment: 
Participants received 90 minutes of treatment a day, five days a week, for six weeks. This 
included 13 minutes of tDCS delivered by a battery-powered constant current stimulator (Dupel 
Iontophoresis System, Empi, MN) via an 8cm2 oblong saline soaked sponge electrode placed 
over the previously identified scalp location. A self-adhesive carbonized reference electrode (48 
cm2) was placed on the forehead above the contralateral orbit. Anodal and cathodal tDCS was 
the same current (1mA) and duration (13 minutes) but differed only in polarity. In the sham 
condition, the stimulation was turned off after 30 seconds.   
 
SLT (90 minutes) was delivered via a computerized ”virtual therapist” and involved reading 
sentences aloud. The first 13 minutes of SLT was concurrent with the 13 minutes of tDCS.     
Temperature, blood pressure and self-reported side effects were measured before and after 
stimulation and at the end of each treatment session. Self-reports were obtained using aphasia-
friendly questionnaires. The same questionnaires were completed in weekly phone calls during 
the 6-week maintenance phase.    
 
Outcome Measures: 
The primary outcome measure was the Aphasia Quotient (AQ) of the WAB-R (Kertesz, 2006). 
The Language Quotient (LQ) of the WAB-R and the Communication Effectiveness Index 
(CETI) serving as secondary outcomes.  
 
Language probes (oral reading of 10 trained and 10 untrained sentences) were taken at baseline 
and weekly during the treatment period. Each word of the sentence was scored on a 5-point scale 
for accuracy. Rate (words per minute) was calculated using recognizable words.  
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Results: 
 
No adverse events were reported. Blood pressure, heart rate, and temperature remained stable 
and within normal limits for all participants during the 6-week treatment and  6-week 
maintenance periods. 
 
Behavioral Measures - Standardized Tests: 
Table 2 shows the mean gain for each group from pretreatment to posttreatment and pretreatment 
to follow-up.  
Both anodal and cathodal groups demonstrated clinically significant improvements for the WAB 
AQ (>5 point gain) and CETI (> than 12 point gain) from pretreatment to post-treatment and 
pretreatment to follow-up.  For the LQ, the anodal group demonstrated clinically significant 
changes (> 5 point gain) for both time intervals; the cathodal group demonstrated clinically 
significant changes from pretreatment to follow-up. The sham group did not meet the criteria for 
clinical significant gains for the AQ, LQ or CETI for either time interval.  It is noteworthy that 
mean performance improved during the maintenance period for the anodal and cathodal groups 
whereas it decreased during maintenance for the sham group.   
Behavioral Measures - Treatment Probes: 
Figure 1 illustrates mean performance of each group on the probes.  Improvements occurred for 
all groups, with overlap across treatment groups. The trajectory of change (slope during 
treatment) appeared the greatest for the cathodal group.   
Table 3 shows percent gain from baseline for accuracy and rate. Percent gain for the anodal and 
cathodal groups was greater than for the sham group for all time intervals except baseline to 
follow-up for accuracy.    
Discussion and Significance: 
Prolonged tDCS to the left hemisphere (1mA for 13 minutes, given 5 days a week for 6 weeks), 
in combination with SLT, was safe.  Six weeks duration of tDCS was longer than any previous 
study in aphasia where the maximum duration has been two weeks.  
Participants received intensive SLT; therefore we expected some language improvement for all 
participants. Beyond this, results indicate that participants receiving either cathodal or anodal 
tDCS performed better on standardized testing and treatment probes than participants receiving 
sham tDCS, and these results were consistent with reported observations on the CETI.   
 
There was persistence of the treatment effect during the six-week maintenance period with 
continued improvements on some measures following the conclusion of treatment. Such gains 
have been noted in other aphasia studies following epidural cortical stimulation (Cherney et al., 
2010) and rTMS (Barwood  et al., 2011; Naeser et al., 2005a,b;  Hamilton et al., 2010). Evidence 
suggests that enhanced neural plasticity with more robust long-term learning and reorganisation 
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of neural circuits plays a role in the improvements in language function associated with the 
delivery of tDCS (Fritsch et al., 2010).  
 
Participants differed on many uncontrollable variables. Although tDCS parameters were kept 
constant (1mA for 13 minutes), differences in head anatomy, including skull thickness, lesion 
size and location, complicate comparisons across participants. 
 
Generalization of findings is limited, given only four participants received each type of tDCS. 
However, results are compelling – six weeks of tDCS combined with SLT is safe and has the 
potential to enhance outcomes. Furthermore, cathodal stimulation to the left hemisphere may be 
a viable option and should not be overlooked in future research on tDCS and aphasia.  
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Table 1. Demographic and language characteristics of study participants 
 
Participant Age   Gender Lesion TPO Education WAB WAB WAB Treatment 
 (years)  size 
(mL) 
(months) (years) AQ LQ CQ  
AQ > 55          
JONRA 46.1 M 66.9 6.3 16 70.3 64.0 70.90 ANODAL 
SHAER 51.5 M 80.3 29.2 16 61.3 61.90 69.73 ANODAL 
LEELO 57.1 F 92.8 38.9 17 74.3 74.80 76.18 CATHODAL 
TONMA 57.8 F 94.7 50.9 16 63.9 71.10 73.52 CATHODAL 
PEACA 55.3 F 76.6 155.7 12 70.1 65.10 69.80 SHAM 
PIWTO 61.4 M 155.8 53.3 13 75.3 65.80 70.32 SHAM 
AQ < 55          
ANDJA 54.4 M 118.6 35.6 12 45.2 46.4 54.18 ANODAL 
HOWSH 55.7 F 136.4 9.2 17 47.1 37.40 42.17 ANODAL 
KARYA 58.8 M 46.5 6.2 16 38.7 37.60 45.83 CATHODAL 
TRAWI 64.9 M 83.3 18.6 18           44.0          58.0 61.57 CATHODAL 
KANJO 71.1 M 24.5 6.2 16 54.3 60.30 65.63 SHAM 
BUTFR 54.7 M 56.1 7.3 18 22.3 30.0 38.42 SHAM 
MEAN 
(SD) 
57.4 
(6.4) 
  34.78 
(41.98) 
15.6 
(2.1) 
55.57 
(16.45) 
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 Table 2. Mean (Std Dev) Gain on Testing from Pretreatment to Post-Treatment and 6-weeks follow-up on the Western 
Aphasia Battery-Revised (WAB) Aphasia Quotient (AQ) and Language Quotient (LQ) and the Communication 
Effectiveness Index (CETI) 
 
 WAB-R AQ WAB-R LQ CETI - Caregiver 
Group Pre - 
Post 
Pre – 
F/Up 
Pre - 
Post 
Pre – 
F/Up 
Pre - 
Post 
Pre – 
F/Up 
Anodal 5.2 
(1.70) 
7.38 
(2.15) 
5.68 
(1.80) 
6.57 
(1.42) 
13.93 
(13.28) 
14.52 
(17.59) 
Cathodal 5.4 
(2.45) 
5.68 
(5.64) 
3.7 
(2.49) 
6.23 
(2.63) 
17.16 
(2.34) 
20.81 
(2.09) 
Sham 4.83 
(7.69) 
3.12 
(8.43) 
4.6 
(2.20) 
3.33 
(3.97) 
7.24 
(6.27) 
10.02        
(8.03) 
Pre-Tx = Pretreatment; Post-Tx = Post treatment; F/Up = Follow Up.  NA = not available 
 
 
 
 
 
Table 3. Group mean percent gain (std  dev) for treatment probes from pretreatment to post-treatment and follow-up  
  
Accuracy Rate 
Group Treatment Baseline to Post-Tx Baseline to F/Up Baseline to Post-Tx Baseline to F/Up 
Group Mean (std dev) ANODAL 47.3 (34.7) 25.7 (0.64)* 63.2 (62.8)  120.7 (74.3)* 
Group Mean (std dev) CATHODAL 47.6 (37.5) 30.2 (47.3) 43.7 (53.4) 140.4 (96.3) 
Group Mean (std dev) SHAM 19.9 (22.8) 32.5 (12.7) 21.4 (55.2) 15.8 (41.6) 
Percent gain calculated as the (mean of 3 post-treatment probes or mean of 2 6-week follow-up probes minus mean of 3 
baseline probes) divided by the mean of 3 baseline probes.   
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Figure 1. Mean Performance on trained probes (oral reading of sentences) 
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